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Abstract Annexin 6 is a Ca2+-dependent phospholipid-binding
protein involved in membrane trafficking. In this study we
demonstrate the association of Raf-1 with recombinant rat
annexin 6. Raf^annexin 6 interaction was shown to be
independent of cell activation by epidermal growth factor
(EGF) or phorbol esters (12-O-tetradecanoyl-phorbol-13-acetate
(TPA)). A stable Chinese hamster ovary (CHO)-anx6 cell line
overexpressing annexin 6 was established to examine the function
of annexin 6. In these cells, no increase of Ras-GTP levels,
induced by EGF or TPA, was detected. In addition, the activity
of Raf was completely inhibited, whereas the mitogen-activated
protein kinase-P was unaffected. ß 2001 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
The annexins are a family of widely expressed calcium/
phospholipid-binding proteins that are highly conserved [1].
In recent years, annexins 1, 2, 4, 6, 7 and 13 have been im-
plicated in membrane tra⁄cking ([1^5] and references there-
in).
Annexin 6 was ¢rst reported at the plasma membrane [6^8]
and later in vesicles of the endocytic compartment [9^13].
More recently, annexins 2 and 6 have been described in iso-
lated subcellular fractions enriched in caveolin, from endothe-
lial cells [14], rat liver [15] and annexin 13a in MDCK cells
[16]. The presence of annexins and other components of the
budding and fusion machinery (i.e. SNAP receptors) has been
associated with the dynamic internalization of caveolae and
their subsequent interaction with the endocytic compartment
[17,18]. Although annexin 6 does not contain the well
conserved predicted caveolin-binding motif, shown by other
molecules reported to interact with caveolin [19], it may inter-
act indirectly through proteins such as PKCK [20], Fyn [21],
¢lamin [22], dynamin [23], H-Ras [24] or as shown in this
study through Raf. Moreover, direct interaction of annexin
6 and the lipids of the cytoplasmic face of caveolae (e.g.
phosphatidylserine (PS)) cannot be ruled out; indeed, annexin
6 and PKC are both calcium-dependent phospholipid-binding
proteins, and their association ^ in the caveolae ^ probably
involves speci¢c protein^protein interactions.
Recently, it was demonstrated that annexin 6 interacts di-
rectly with the conserved region 2 (C2) domain of key Ras
regulatory p120-GTPase activating protein (p120GAP) which
forms part of a protein complex containing Fyn and Pyk2
[25]. This was an additional indication that annexin 6 could
be involved in the regulation of signal transduction, through
the ‘bridging’ of a protein complex formation with Fyn and
Pyk2, two tyrosine kinases associated with the regulation of
Ras. The C2 domains function as Ca2 sensors in signaling
proteins and therefore it is tempting to speculate that annexin
6 may be linked with a Ca2-mediated regulation of p21 Ras
activity [26].
Finally, the fact that GAP [27] and Raf-1 [28,29] were lo-
calized in endosomes may indicate that recruitment to the
plasma membrane (caveolae), upon stimulation of cell surface
receptor (e.g. by epidermal growth factor (EGF)), is transient
and these proteins cycle to the endocytic compartment which
might be their steady-state/functional location. Therefore, the
assembling of signaling ‘modules’ ^ and their subsequent
transport from the caveolae to the endocytic compartment ^
can be a key event which might be mediated by annexin 6.
2. Materials and methods
2.1. Reagents and antibodies
Nutrient mixture F-12 Ham medium, geneticin, glutathione, 12-O-
tetradecanoyl-phorbol-13-acetate (TPA) and EGF were from Sigma
Chemical Co. (Madrid, Spain). Fetal calf serum (FCS) was purchased
from Biological Industries (Ben Haemeck, Israel). Glutathione-aga-
rose beads and the pGEX expression system were from Amersham
Pharmacia Biotech (Uppsala, Sweden). Peroxidase-labeled antibodies
and SDS^PAGE molecular weight markers were from Bio-Rad. Anti-
GAP monoclonal antibody was purchased from Upstate Biotechnol-
ogy, Inc. (Lake Placid, NY, USA); anti-Raf monoclonal antibody
was from Transduction Laboratories (Lexington, KY, USA); the rab-
bit antibody against phosphorylated mitogen-activated protein kinase
(MAPK) was purchased from Cell Signaling (Beverly, MA, USA) and
the monoclonal anti-H-Ras antibody was from Santa Cruz Technol-
ogy, Inc. (Santa Cruz, CA, USA).
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2.2. GST (glutathione-S-transferase)-anx6 pull-down
Chinese hamster ovary (CHO) cells were grown in Ham’s F-12
supplemented with 10% FCS. Annexin 6 overexpressing CHO cells
were grown in the presence of 1 mg/ml G418. 75 Wg of GST-anx6
and 21 Wg of GST were incubated for 90 min with glutathione-Se-
pharose at 4‡C in phosphate-bu¡ered saline. After washing in 50 mM
Tris, 100 mM NaCl, 1% Triton X-100, 0.1 mM CaCl2 (lysing bu¡er),
GST-anx6-Sepharose was then incubated with 600 Wg cell extract for
2 h at 4‡C and collected by a pulse of a centrifuge. Proteins bound to
the column were washed and analyzed by electrophoresis and Western
blot. Cell extracts for the a⁄nity column were previously deprived of
serum for 16 h (overnight), after which cells were either not treated or
stimulated with 10 ng/ml EGF or 100 nM TPA. Cells were then
placed in cold lysing bu¡er, scraped and centrifuged.
2.3. Measurement of Ras activation
The capacity of Ras-GTP to bind to RBD (Ras-binding domain of
Raf-1) was used to analyze the amount of active Ras [30]. Cells
(2U106) were lysed in the culture dish with bu¡er (20 mM Tris^
HCl, pH 7.5, 2 mM EDTA, 100 mM NaCl, 5 mM MgCl2, 1% (v/v)
Triton X-100, 5 mM NaF, 10% (v/v) glycerol, 0.5% (v/v) L-mercap-
toethanol, 0.1 mM Na3VO4; 1 mM PMSF, 1 mM aprotinin and 20 WM
leupeptin). Cleared (10 000Ug) lysate was assayed for protein con-
centration by the Bradford method and protein-equalized superna-
tants were incubated for 2 h at 4‡C with glutathione-Sepharose-4B
beads pre-coupled with GST^RBD (1 h, 4‡C). Beads were washed
four times in the lysis bu¡er. Bound proteins were solubilized with
Laemmli loading bu¡er and electrophoresed on 12.5% SDS^PAGE
gels. Proteins were then transferred and immunoblotted using anti-
(Pan)-Ras (Ab-3, OP-40, Oncogene Sciences, 1 Wg/ml) monoclonal
antibody.
2.4. Raf-1 kinase activity assays
To measure Raf-1 activity, kinase assays following immunoprecipi-
tation were performed essentially as described [31]. Brie£y, cells
(2U106) were harvested on ice in lysis bu¡er (50 mM Tris^HCl, pH
7.4, 150 mM NaCl, 1 mM CaCl2, 1% (v/v) Triton X-100, 5 mM NaF,
0.1 mM Na3VO4, 1 mM PMSF, 1 mM aprotinin and 20 WM leupep-
tin) and clari¢ed by centrifugation (10 000Ug). Supernatants (equal-
ized for protein concentration) were then immunoprecipitated for 2 h
at 4‡C with 2 Wg of anti-Raf-1 (Transduction Laboratories, Lexing-
ton, KY, USA) pre-coupled with 20 Wl of protein G-Sepharose
(Pierce, Rockford, IL, USA) (2 h at room temperature). Immunopre-
cipitates were then washed three times in bu¡er (30 mM Tris, 0.1 mM
EDTA, 0.3% L-mercaptoethanol, 10% glycerol, 0.1% (v/v) Triton X-
100, 5 mM NaF, 0.2 mM Na3VO4) with decreasing amounts of NaCl
(high: 1 M, low: 0.1 M and salt-free). Washed immunoprecipitates
were incubated for 30 min at 30‡C in 20 Wl of MEK bu¡er (30 mM
Tris, 0.1 mM EDTA, 0.3% L-mercaptoethanol, 10 mM MgCl2, 0.1%
(v/v) Triton X-100, 5 mM NaF, 0.2 mM Na3VO4, 0.8 mM ATP,
6.5 Wg/ml GST-MEK, 100 Wg/ml GST-ERK2), and the reaction was
terminated by the addition of 20 Wl of ice-cold stop bu¡er (30 mM
Tris, 6 mM EDTA, 0.3% L-mercaptoethanol, 0.1% (v/v) Triton X-100,
5 mM NaF, 0.2 mM Na3VO4). Following centrifugation, 6 Wl of
supernatants was incubated for 15 min at 30‡C with 24 Wl of MBP
(myelin basic protein) bu¡er (50 mM Tris, 0.1 mM EDTA, 0.3%
L-mercaptoethanol, 10 mM MgCl2, 0.1% (v/v) Triton X-100, 5 mM
NaF, 0.2 mM Na3VO4, 0.1 mM ATP, 2.5 Wl [32P]ATP, 0.5 Wg/Wl
MBP, 0.16 Wg/Wl bovine serum albumin), and then aliquots of 24 Wl
were loaded onto P81 sheets, and washed three times (20 min each) in
75 mM orthophosphoric acid and counted.
2.5. Recombinant DNA
The construction of the rat annexin VI expression vector
pcDNAanx6 has been described recently [4]. Recombinant full length
annexin 6 (GST-anx6) and truncated GST-anx61ÿ175 were obtained as
GST fusion proteins [32]. Cloning of the 2.0 kb full length annexin 6
NcoI^XbaI fragment into pGEX-KG (Pharmacia) generated pGEX-
anx6. Cloning of a 542 bp HindIII^AspI annexin 6 cDNA fragment
containing coding sequences from position +1 to position +527, which
lack six of the eight annexin 6 repeats at the carboxy-terminal, gen-
erated pGEX-anx61ÿ175. All cloning procedures were performed ac-
cording to standard protocols [33]. GST-anx6 was expressed in Esche-
richia coli strain BL21 pLys and puri¢ed by glutathione-Sepharose
chromatography.
2.6. Annexin 6 stable CHO cells
To generate stable annexin 6 overexpressing cells, 1U106 CHO cells
were transfected with 10 Wg pcDNAanx6 and the FUGENE1 6
Transfection Reagent (Boehringer Mannheim). G418 (1 mg/ml) was
added 24 h after transfection, and 13 days later G418-resistant colo-
nies were isolated and examined for expression of annexin 6 by West-
ern blotting and immuno£uorescence [4].
2.7. Other procedures
SDS^PAGE and Western blotting. CHO cell lysates or samples
from pull-down experiments were separated by SDS^PAGE [34] and
transferred to Immobilon-P (Millipore), followed by incubation with
the appropriate peroxidase-conjugated secondary antibodies and en-
hanced chemiluminescence detection (Amersham Pharmacia Biotech).
3. Results and discussion
Raf-1 is a Ser/Thr kinase that plays a crucial role in the
signal transduction pathway initiated by growth factors or via
PKC [35]. Upon activation, Raf-1 is recruited to the plasma
membrane or to the early/sorting endocytic compartment [36^
38] where is activated by Ras-GTP, by mechanisms that are
poorly understood. Downstream events involve the phosphor-
ylation of the kinase MEK, leading to stimulation of the
MAPK. Where and how Raf-1 is regulated remains to be
established.
At least three independent lines of evidence implicate an-
nexin 6 in signal transduction pathways: ¢rst, it interacts di-
rectly with the C2 domain of the key Ras regulatory protein
p120GAP [25,39]. GAP is a GTPase activating protein pro-
posed to accelerate the inhibition of Ras. Second, in A431
cells EGF-dependent calcium in£ux was inhibited by annexin
6 [40]. And third, annexin 6 may play an important role in the
Fig. 1. Interaction of annexin 6 with Raf-1 in CHO cells. Pull-down
experiments using GST-anx6 were performed to study the interac-
tions of annexin 6 with proteins of the signal transduction machi-
nery. CHO cell extracts were incubated with GST-anx6 for 2 h at
4‡C. Bound proteins (GST-anx6) were collected, separated by
PAGE and analyzed by Western blotting, using antibodies to Raf-1,
MEK, MAPK and GAP. Controls with GST alone showed no
binding. The mutated form of annexin 6 (annexin 61ÿ175, which
lacks six of the eight repeats) did not bind to Raf-1.
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recruitment (assembly) of protein complexes at the caveolae,
including the constituents of the signal transduction machi-
nery and calcium signaling.
3.1. GST-annexin 6 (GST-anx6) interacts with Raf-1 in CHO
cells
Thus, to analyze the possible interaction of annexin 6 with
the signal transduction machinery, extracts of CHO cells were
incubated with immobilized recombinant GST-anx6 protein.
In agreement with data previously reported we identi¢ed GAP
in the GST-anx6-binding fraction. In addition, immunoblot
analysis of pull-down fractions showed the interaction of
Raf-1 with GST-anx6. In contrast Western blots of the
GST-anx6 bound fraction did not reveal the presence of
MEK or MAPK-P proteins (Fig. 1). Besides, in a preliminary
attempt to identify the domain of annexin 6 protein interact-
ing with Raf-1, GST pull-down experiments were performed
with a truncated mutant fusion protein (lacking six of the
eight repeats) GST-anx61ÿ175 (Fig. 1). In these experiments
Raf-1 did not bind to GST-anx61ÿ175, suggesting that the
binding of Raf-1 to annexin 6 was not mediated through
the N-terminal region of annexin 6. Binding of GAP to an-
nexin 6 was located at the interlobular region of annexin 6,
where the two lobules can rotate 90‡, thus changing its con-
formation [41].
3.2. Interaction of Raf with annexin 6 is independent of cell
activation
To ¢nd out whether the interaction of Raf-1 with annexin 6
was dependent upon cellular activation, two approaches were
followed: ¢rst, CHO cells were serum-deprived for 16 h and
then stimulated with EGF. In a time course experiment (2^15
min) it can be observed that there were no changes in the
binding to Raf-1. Although these cells showed very low levels
of EGF-R [42], the activation of MAPK (MAPK-P) was ob-
served and it reached a peak after 2 min of EGF treatment,
decreasing after 5 min, shown in lysates (Fig. 2).
Second, CHO cells were treated with TPA (for 2 min) which
is more e⁄cient than EGF in the MAPK-P pathway, in this
cell line. No di¡erences in the binding of Raf-1 to GST-anx6,
compared to control untreated cells, were observed (Fig. 3).
Extracts of CHO cells were also assayed for binding of GST-
anx6 with GAP and MAPK-P; the binding to Raf-1 was also
independent of the presence of Ca2 or PS (not shown). Op-
posite to EGF, in lysates of CHO cells treated with TPA, the
MAPK-P activity was sustained for 30 min (not shown).
3.3. Overexpression of annexin 6 inhibits Raf-1 activity
Since CHO cells have very low levels of annexin 6 [4], to
understand the functional role of the annexin 6^Raf-1 com-
plexes, we performed the same experiments but in CHO cells
stably transfected with annexin 6 cDNA (CHO-anx6). The
overexpression of annexin 6 had no e¡ect on the MAPK-P
activation by EGF or TPA, or on the interaction with Raf-1
or GAP (not shown). However, when the activity of Raf-1
was examined in CHO-anx6 cells, stimulated with EGF or
with TPA, Raf-1 activity decreased, compared with wild-
type (wt) CHO, where Raf-1 activity increased 12% and
60% after EGF and TPA treatment, respectively (Fig. 4).
The low activation of Raf-1, by EGF, in the CHO cells
Fig. 2. Association of annexin 6 with Raf-1 is independent of EGF
activation. Pull-down experiments using GST-anx6 were performed
to study the interactions of annexin 6 with Raf-1, MEK-P and
MAPK-P after stimulation of CHO cells with EGF for 2, 5 or
15 min. CHO cell extracts were incubated with GST-anx6 as de-
scribed in Fig. 1. Bound proteins (GST-anx6) were collected, and
analyzed by Western blotting, using antibodies to Raf-1, MEK-P
and MAPK-P. The association of annexin 6 to Raf-1 is independent
of cell activation by EGF. A peak of MEK-P and MAPK-P activity
was restricted to 2 min.
Fig. 3. Interaction of annexin 6 with Raf-1 and GAP is independent
of cell activation. CHO cells were serum-deprived for 16 h and
stimulated with EGF (10 ng/ml) or TPA (100 nM) for 2 min. Cell
extracts were incubated with GST-anx6 as described above (pull-
down assay) and the bound material or lysates analyzed by Western
blotting with Raf-1, GAP or MAPK-P antibodies. Interaction of
annexin 6 with Raf-1 and to GAP was independent of TPA activa-
tion.
Fig. 4. Activation of Raf in CHO-wt and CHO-anx6 cells. Cells
were deprived of serum for 16 h and stimulated with EGF (10 ng/
ml) or TPA (100 nM) for 2 min. The activity of Raf was measured
from CHO cell extracts by immunoprecipitation with the anti-Raf
antibody and kinase cascade assay, with GST-MEK, GST-ERK2
and MBP as substrates. The results show a representative experi-
ment assayed in triplicate (n = 3 þ S.D.). Open bars, control; gray
bars, EGF; black bars, TPA.
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may be explained, as mentioned before, by the low number of
EGF-R.
Thus, to determine whether the decreased Raf-1 activity in
CHO-anx6 cells was caused by interaction of annexin 6 and
Raf-1 or due to an upstream event, the amount of Ras-GTP
was monitored by its association with the GST^RBD fusion
protein. Cell extracts of non-activated or EGF/TPA-activated
(for 2 min) CHO cells and CHO-anx6 overexpressing cells
were incubated with immobilized GST^RBD, and bound
Ras-GTP protein was detected by Western blotting. Fig. 5
shows the comparison of the total amount of Ras-GTP
(anti-Pan-Ras antibody) in pull-down fractions from CHO-
wt or CHO-anx6 cells. Fig. 5a shows that the amount of
Ras-GTP was signi¢cantly reduced in EGF or TPA-stimu-
lated CHO-anx6 cells ; lysates showed MAPK-P was not af-
fected (EGF or TPA), indicating that the activation of MAPK
was produced by a di¡erent/independent mechanism (Fig. 5c).
Finally, in order to determine whether the annexin 6 over-
expression inhibited Ras-GTP (and downstream Raf-1) or just
delays it, we performed a time course study, from 2 to 10 min,
in the CHO-wt and CHO-anx6 cells treated with TPA. Fig.
5d,e shows that there is a peak of Ras activation (Ras-GTP)
at 2 min in the CHO-wt which was signi¢cantly inhibited in
CHO-anx6 cells and no further activation was detected up to
10 min. Although a slightly increased amount of Ras-GTP
was observed in the CHO-anx6 cells at the 2 min point, it
was much less, and not signi¢cant compared with CHO-wt
cells (the same variability was observed in the Raf assay,
Fig. 4, also at 2 min). In all experiments the same amount
of protein was loaded for the Western blotting analysis.
In comparison with recent studies in which a Ras mutant
blocks activation of MAPK after receptor tyrosine kinase
stimulation but not in response to activation by PKC [43],
we have demonstrated that in CHO-wt cells Ras was activated
after stimulation by either EGF or TPA. This is in agreement
with the requirement of Ras-GTP^Raf-1 complexes to acti-
vate Raf-1 in response to TPA [44]. Ras activation by phorbol
esters is also required for MAPK phosphorylation in cardiac
myocytes, but not in cardiac ¢broblasts [45]. Thus, whereas in
CHO-wt cells the MAPK pathway can be activated via Ras/
Raf or by a di¡erent (independent) pathway, in CHO-anx6
cells only this Ras/Raf-independent pathway seems to be op-
erative, for the activation of MAPK. Since GTP is more
abundant than GDP and Ras molecules are ¢lled spontane-
ously by GTP, the decreased Ras-GTP levels in CHO-anx6
cells suggest a possible annexin 6-mediated inhibition of Ras-
GDP dissociation. Furthermore, the GAP speeds up Ras de-
activation binding to the Ras-GTP complex. Overexpression
of annexin 6 could therefore facilitate/contribute to the inhi-
bition of Ras by the GAP^Ras-GTP assembly.
Finally, annexin 6 has been found in caveolae, clathrin-
coated pits and in endosomes but its location may depend
on Ca2 mobilization in the cell [46]. In caveolae, interactions
of proteins with PKCK, dynamin, Raf-1 or other kinases may
in£uence the regulation of signal transduction downstream
events. Caveolin, through its sca¡olding domain, interacts
with molecules of the signal transduction machinery and an-
nexins (e.g. annexins 2 and 6) might be involved in the assem-
bly of those complexes and with the lipid bilayer.
Thus, as occurred (with TPA) for annexin 5 [47], in annexin
6 overexpressing cells the increase in Ras/Raf signaling caused
by EGF or TPA was suppressed, and this inhibition occurs at
the level or upstream of Ras-GTP; although, a downstream
e¡ect, directly on Raf activity, cannot be ruled out. The fact
that MAPK activity was not a¡ected indicates an alternative
(independent) signaling pathway.
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